Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.

被引：394

作者：

Davidson, R

Cavalcanti, R

Brunton, JL

Bast, DJ

de Azavedo, JCS

Kibsey, P

Fleming, C

Low, DE

机构：

[1] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada

[2] Toronto Med Labs, Toronto, ON, Canada

[3] Mt Sinai Hosp, Toronto Med Labs, Toronto, ON M5G 1X5, Canada

[4] Univ Hlth Network, Toronto, ON, Canada

[5] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[6] Univ Toronto, Toronto, ON, Canada

[7] Victoria Gen Hosp, Victoria, BC, Canada

[8] Ontario Med Assoc, Lab Serv, Qual Management Program, Toronto, ON, Canada

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 346卷 / 10期

关键词：

D O I：

10.1056/NEJMoa012122

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：747 / 750

页数：4

共 23 条

[1]

[Anonymous], M100S11 NCCLS

[2]

Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954

[3] Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae:: Contributions of type II topoisomerase mutations and efflux to levels of resistance [J].

Bast, DJ ;

Low, DE ;

Duncan, CL ;

Kilburn, L ;

Mandell, LA ;

Davidson, RJ ;

de Azavedo, JCS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3049-3054

[4] Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].

Chen, DK ;

McGeer, A ;

de Azavedo, JC ;

Low, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239

[5] Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses [J].

Chien, SC ;

Rogge, MC ;

Gisclon, LG ;

Curtin, C ;

Wong, F ;

Natarajan, J ;

Williams, RR ;

Fowler, CL ;

Cheung, WK ;

Chow, AT .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2256-2260

[6] A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia [J].

File, TM ;

Segreti, J ;

Dunbar, L ;

Player, R ;

Kohler, R ;

Williams, RR ;

Kojak, C ;

Rubin, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :1965-1972

[7] The specific polysaccharide content of pneumonic lungs [J].

Frisch, AW ;

Tripp, JT ;

Barrett, CD ;

Pidgeon, BE .

JOURNAL OF EXPERIMENTAL MEDICINE, 1942, 76 (06) :505-510

[8] Management of community-acquired pneumonia in the era of pneumococcal resistance -: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group [J].

Heffelfinger, JD ;

Dowell, SF ;

Jorgensen, JH ;

Klugman, KP ;

Mabry, LR ;

Musher, DM ;

Plouffe, JF ;

Rakowsky, A ;

Schuchat, A ;

Whitney, CG .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) :1399-1408

[9] Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong [J].

Ho, PL ;

Que, TL ;

Tsang, DNC ;

Ng, TK ;

Chow, KH ;

Seto, WH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1310-1313

[10] Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae:: A case-control study [J].

Ho, PL ;

Tse, WS ;

Tsang, KWT ;

Kwok, TK ;

Ng, TK ;

Cheng, VCC ;

Chan, RMT .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) :701-707

← 1 2 3 →